Justification For The Use Of Statins In Prevention: An Intervention Trial Evaluating Rosuvastatin: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Redirected page to JUPITER Trial)
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
{{SI}}
#Redirect [[JUPITER Trial]]
 
<font color="blue">How to edit trial information:</font> <small> [[Special:UserLogin|Log in]], click on the word [<font color="blue">edit</font>] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements required by the World Health Organization. You can add additional sections.</small> [[Help:How to add a trial to the clinical trial wiki|More help to add a trial here.]]
 
 
== Complete Title of Study ==
None reported
 
==Study Acronym <small>(The trial's abbreviation if there is one) </small>==
None reported
 
==Principal Investigator, Co-investigators, and Collaborating Institutions==
None reported
 
==Overview of Trial==
None reported
 
==Disease State(s) Studied <small>(e.g. acute MI, breast cancer, etc.)</small>==
None reported
 
==Study Phase <small>(e.g. Phase I,II,III,IV) [[Study phase|Study Phases are defined here]]</small>==
None reported
 
==Study Design <small>(e.g. multicenter, randomized, double blind, placebo controlled)</small>==
None reported
 
== Study Arms and How They Were Treated (Intervention) <small>[[Study arms|(Explanation here)]]</small>==
None reported
 
== Primary Pre-Specified Endpoint ==
None reported
 
== Secondary Endpoints ==
None reported
 
== Inclusion Criteria ==
None reported
 
==Exclusion Criteria==
None reported
 
==Outcome: Primary endpoint <small>(Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)</small>==
None reported
 
==Outcome: Secondary endpoint <small>(Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)</small>==
None reported
 
==Outcome: Exploratory endpoints <small>(Report both relative risk reduction and absolute risk reduction as well as number needed to treat if available)</small>==
None reported
 
==Outcome: Safety endpoints <small>(Report both relative risk and absolute risk as well as number needed to harm if available)</small>==
None reported
 
==Conclusions of the Investigators <small>(Quote the investigators conclusions here)</small>==
None reported
 
==Commentary, Discussion and Limitations of the Trial<small> (Anyone can add comments)</small>==
None reported
 
==Slides==
None reported
 
==Video Commentary==
None reported
 
== References [[Help:Adding_References_to_Articles|(How to insert a reference)]]==
None reported
 
==External sites for further information <small>[[Help:Links|(How to insert links)]]</small>==
None reported
 
==Detailed information about the trial==
==Ages==
__ years to ___ years
 
==Gender <small>(Indicate whether men, women or both were enrolled)</small>==
None reported
 
==Accepts Healthy Volunteers <small>(Answer yes or no)</small>==
None reported
 
==Enrollment Period <small>(Study start and end date)</small>==
None reported
 
==Recruitment Status [[Recruitment status|(explanation)]]==
None reported
 
==Enrollment <small>(Total number of patients enrolled)</small>==
None reported
 
==Study Sponsor <small>(e.g. Investigator initiated or company name)</small>==
None reported (this may not have yet been ascertained)
 
==Source of Data <small>(Where is this data on this page coming from: publication, principal investigator, or co-investigator)</small>==
None reported
 
 
The content of the clinical trial wiki consists of fields that have been suggested by the World Health Organization and wwww.clinicaltrials.gov.
 
[[Category:Clinical trials]]
 
{{WH}}
 
{{WS}}

Latest revision as of 03:39, 29 September 2014

Redirect to: